176 related articles for article (PubMed ID: 34603298)
1. Mice Plasmacytoid Dendritic Cells Were Activated by Lipopolysaccharides Through Toll-Like Receptor 4/Myeloid Differentiation Factor 2.
Zhang W; An EK; Hwang J; Jin JO
Front Immunol; 2021; 12():727161. PubMed ID: 34603298
[TBL] [Abstract][Full Text] [Related]
2. Plasmacytoid dendritic cells mature independently of MyD88 and IFN-αβR in response to Listeria and stimulate CD8 T cells.
Tam MA; Wenzel UA; Wick MJ
Immunol Lett; 2011 Aug; 138(2):104-12. PubMed ID: 21453725
[TBL] [Abstract][Full Text] [Related]
3. Human Metapneumovirus M2-2 Protein Acts as a Negative Regulator of Alpha Interferon Production by Plasmacytoid Dendritic Cells.
Kitagawa Y; Sakai M; Funayama M; Itoh M; Gotoh B
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768858
[TBL] [Abstract][Full Text] [Related]
4. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
5. Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.
Dai P; Cao H; Merghoub T; Avogadri F; Wang W; Parikh T; Fang CM; Pitha PM; Fitzgerald KA; Rahman MM; McFadden G; Hu X; Houghton AN; Shuman S; Deng L
J Virol; 2011 Oct; 85(20):10814-25. PubMed ID: 21835795
[TBL] [Abstract][Full Text] [Related]
6. TLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta priming.
Richez C; Yasuda K; Watkins AA; Akira S; Lafyatis R; van Seventer JM; Rifkin IR
J Immunol; 2009 Jan; 182(2):820-8. PubMed ID: 19124725
[TBL] [Abstract][Full Text] [Related]
7. Activation of interferon regulatory factor 7 in plasmacytoid dendritic cells promotes experimental autoimmune pancreatitis.
Minaga K; Watanabe T; Arai Y; Shiokawa M; Hara A; Yoshikawa T; Kamata K; Yamashita K; Kudo M
J Gastroenterol; 2020 May; 55(5):565-576. PubMed ID: 31960143
[TBL] [Abstract][Full Text] [Related]
8. Type I interferon dependence of plasmacytoid dendritic cell activation and migration.
Asselin-Paturel C; Brizard G; Chemin K; Boonstra A; O'Garra A; Vicari A; Trinchieri G
J Exp Med; 2005 Apr; 201(7):1157-67. PubMed ID: 15795237
[TBL] [Abstract][Full Text] [Related]
9. Carbon monoxide down-modulates Toll-like receptor 4/MD2 expression on innate immune cells and reduces endotoxic shock susceptibility.
Riquelme SA; Bueno SM; Kalergis AM
Immunology; 2015 Feb; 144(2):321-32. PubMed ID: 25179131
[TBL] [Abstract][Full Text] [Related]
10. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
11. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
[TBL] [Abstract][Full Text] [Related]
12. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.
Erridge C; Kennedy S; Spickett CM; Webb DJ
J Biol Chem; 2008 Sep; 283(36):24748-59. PubMed ID: 18559343
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
14. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
Front Immunol; 2018; 9():3070. PubMed ID: 30622542
[TBL] [Abstract][Full Text] [Related]
15. Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming.
Hervas-Stubbs S; Riezu-Boj JI; Mancheño U; Rueda P; Lopez L; Alignani D; Rodríguez-García E; Thieblemont N; Leclerc C
J Immunol; 2014 Aug; 193(3):1151-61. PubMed ID: 24973449
[TBL] [Abstract][Full Text] [Related]
16. Diminished secretion and function of IL-29 is associated with impaired IFN-α response of neonatal plasmacytoid dendritic cells.
Wisgrill L; Wessely I; Netzl A; Pummer L; Sadeghi K; Spittler A; Berger A; Förster-Waldl E
J Leukoc Biol; 2019 Nov; 106(5):1177-1185. PubMed ID: 31211458
[TBL] [Abstract][Full Text] [Related]
17. CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells.
Frleta D; Noelle RJ; Wade WF
J Leukoc Biol; 2003 Dec; 74(6):1064-73. PubMed ID: 12960264
[TBL] [Abstract][Full Text] [Related]
18. Monocyte-mediated inhibition of TLR9-dependent IFN-α induction in plasmacytoid dendritic cells questions bacterial DNA as the active ingredient of bacterial lysates.
Poth JM; Coch C; Busch N; Boehm O; Schlee M; Janke M; Zillinger T; Schildgen O; Barchet W; Hartmann G
J Immunol; 2010 Dec; 185(12):7367-73. PubMed ID: 21057083
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
[TBL] [Abstract][Full Text] [Related]
20. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
